苏州宇测生物科技有限公司

Development and validation of machine learning models with blood-based digital biomarkers for Alzheimer’s disease diagnosis: a multicohort diagnostic study 【亮点】： 由中南大学湘...

Neuronal FAM171A2 mediates α-synuclein fibril uptake and drives Parkinson’s disease 【亮点】： 由我国顶尖科研团队联合攻关的帕金森病研究取得重大突破！ 复旦大学附属华山医院郁金泰教...

Tau pathology mediated the plasma biomarkers and cognitive function in patients with mild cognitive impairment 【亮点】： 由上海交通大学医学院附属精神卫生中心的李霞教授通讯，在...

Genetic spectrum features and diagnostic accuracy of four plasma biomarkers in 248 Chinese patients with frontotemporal dementia 【亮点】： 由中南大学湘雅医院神经内科沈璐教授和焦彬研...

Novel diagnostic and prognostic approach for rapidly progressive dementias: Indicators based on amyloid/tau/ neurodegeneration (ATN) framework 【亮点】： 2024年7月16日，复旦大学附属...

Synaptic vesicle glycoprotein 2 A in serum is an ideal biomarker for early diagnosis of Alzheimer’s disease 【亮点】： 2024年4月13日，首都医科大学宣武医院的王培昌教授（主要通讯）和贾建平教...

P-tau217 correlates with neurodegeneration in Alzheimer's disease, and targeting p-tau217 with immunotherapy ameliorates murine tauopathy 【亮点】： ： 2024年...

Alzheimer’s disease early diagnostic and staging biomarkers revealed by large-scale cerebrospinal fluid and serum proteomic profiling 【亮点】: 1、由浙江...